Home ContractsA multi-drug resistant pathogen reference strain a…

A multi-drug resistant pathogen reference strain and clinical isolate collection

WAC ID:127406

Private SectorAward noticeClosed32014L0024

Source:	Find a Tender Service (FTS)
Notice Type:	Award notice
Buyer:	MEDICINES DISCOVERY CATAPULT SERVICES LIMITED
Main Category:	Services
Procurement Method:	Award procedure without prior publication of a call for competition
Method Rationale:	Following the voluntary ex ante transparency (VEAT) notice previously published, indicating that Medicines Discovery Catapult, intends to enter into a contract with the UK Health Security Agency (UKHSA) for a multi-drug resistant pathogen reference strain and clinical isolate collection without a call to competition in accordance with the Public Contracts Regulations 2015 ((32.2(b) ii), Medicines Discovery Catapult has now entered into the contract with UKHSA. The contract is directly aligned to the PACE (Pathways to Antimicrobial Clinical Efficacy) first funding call that can be used by the provider to generate antimicrobial susceptibility data across PACE-funded projects and that can be made available to PACE awardees for onward project progression and will allow continued expansion and characterisation of the strain and isolate collection to ensure it remains reflective of contemporary and genomically diverse multi-drug resistant and epidemic lineages of target pathogens (~20-30 strains) across E. coli, K. pneumoniae, P. aeruginosa, A. baumannii and S. aureus. This expanded collection will be made available for antimicrobial susceptibility testing (AST) across PACE-funded projects and the wider AMR community. The UKHSA maintains unique capabilities and assets that are part of the country's critical national infrastructure to support this aim, this includes; The English surveillance programme for antimicrobial utilisation and resistance (ESPAUR), which identifies emergence and trends in key resistance-causing pathogens. The AMRHAI (antimicrobial resistance and healthcare associated infections) national reference unit, part of the Bacteriology reference department (BRD) - a national and international laboratory reference centre for a bacterial infections. The isolate bank will be evolved using the latest surveillance and national reference laboratory data on clinical isolates currently circulating nationally and internationally and; UKHSA AMR labs then enable rapid characterisation of new isolates including full antibiogram and whole genome sequencing.

Award outcome

Awarded to

UK Health Security AgencyGB-FTS-104454

Award status:

Active

Contracting Authority

Organisation

MEDICINES DISCOVERY CATAPULT SERVICES LIMITED

Description

A multi-drug resistant pathogen reference strain and clinical isolate collection representative of pathogens and resistance mechanisms directly aligned to the PACE first funding call that can be used by the provider to generate antimicrobial susceptibility data across PACE-funded projects and that can be made available to PACE awardees for onward project progression. Continued expansion and characterisation of the strain and isolate collection to ensure it remains reflective of contemporary and genomically diverse multi-drug resistant and epidemic lineages of target pathogens (~20-30 strains) across E. coli, K. pneumoniae, P. aeruginosa, A. baumannii and S. aureus. This expanded collection will be made available for antimicrobial susceptibility testing (AST) across PACE-funded projects and the wider AMR community.

CPV Classifications1 code — click to expand

73200000Research and development consultancy services